Sanofi (NYSE: SNY) and its specialty care global business unit Sanofi Genzyme announced today positive new six-year investigational data from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE